Related Experiment Video
Updated: Feb 16, 2026

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
TNFR2: The new Treg switch?
José L Cohen1, Kathryn J Wood2
1Université Paris-Est, Unité mixte de recherche S955, Université Paris Est Créteil, Créteil, France; INSERM, U955, Equipe 21, Créteil, France; Assistance Publique Hôpitaux de Paris (APHP), Hôpital H. Mondor-A. Chenevier, Centre d'Investigation Clinique Biothérapie, Créteil, France.
The TNF/TNR2 pathway is a novel target for immune checkpoint therapy. Modulating this pathway can reduce graft-versus-host disease or enhance anti-leukemic effects in stem cell transplantation.
Area of Science:
- Immunology
- Oncology
- Transplantation
Background:
- Allogeneic hematopoietic stem cell transplantation (HSCT) is a critical treatment for hematologic malignancies.
- Graft-versus-host disease (GVHD) and relapse remain significant challenges in HSCT.
- Regulatory T cells (Tregs) play a crucial role in immune tolerance and antitumor immunity.
Purpose of the Study:
- To identify novel therapeutic targets for modulating immune responses in HSCT.
- To explore the role of the Tumor Necrosis Factor (TNF)/TNFR2 pathway in HSCT outcomes.
- To investigate the potential of targeting the TNF/TNFR2 pathway for immune checkpoint therapy.
Main Methods:
- Review of recent publications identifying the TNF/TNFR2 pathway.
- Analysis of Treg activation and blockade in the context of HSCT.
- Evaluation of the TNF/TNFR2 pathway as a target for immune modulation.
Main Results:
- The TNF/TNFR2 pathway was identified as a key regulator in HSCT.
- Targeting this pathway can reduce GVHD via Treg activation.
- Blocking the pathway may enhance anti-leukemic effects through Treg modulation.
Conclusions:
- The TNF/TNFR2 pathway represents a promising target for immune checkpoint therapy in HSCT.
- Modulation of this pathway offers a dual approach to improve HSCT efficacy and safety.
- Further research into TNF/TNFR2 targeted therapies is warranted for clinical application.
Related Concept Videos
Switching of BJT
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
GTPases and their Regulation
Large G-proteins,...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Milgram's Obedience to Authority
Intrinsically Disordered Proteins

